600085 Beijing Tongrentang
- 33.96
- +0.06+0.18%
Beijing Tongrentang News
Beijing Tongrentang Announcement on the completion of the board of directors, special committees, supervisory board elections, and the appointment of senior management personnel.
Beijing Tongrentang's announcement of the 2023 Annual Shareholders' Meeting resolution.
Legal opinion from Beijing Dacheng Law Firm regarding the 2023 shareholder meeting of Beijing Tongrentang Co., Ltd.
Beijing Tongrentang's 2023 annual shareholder meeting materials.
Beijing Tongrentang Announcement on the Election of Employee Representatives of the 10th Supervisory Board
Beijing Tongrentang Co., Ltd. 2024 “Improve Quality, Increase Efficiency and Value Return” Action Plan
Notice of Tong Ren Tang on the holding of the 2023 Annual General Meeting of Shareholders
Tong Ren Tang's announcement on the appointment of an accounting firm
Tong Ren Tang's announcement on the election of the Board of Directors and the Board of Supervisors for a new term
Tong Ren Tang 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors of Tong Ren Tang in 2023
Special report by the board of directors of Tong Ren Tang on the self-inspection of the independence of independent directors
Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accounting firms for the 2023 annual review
Tongrentang's announcement on the subsidiary obtaining a notice of approval for drug clinical trials
Written review opinions of the Audit Committee of the Board of Directors of Tong Ren Tang on property leasing and related transactions of the company and its holding subsidiaries
Written audit opinion of the Audit Committee of the Board of Directors of Tong Ren Tang on loans and related transactions entrusted by the controlling shareholder to the company and its holding subsidiaries
Tong Ren Tang\'s announcement on its pharmaceutical company obtaining a notice of approval for supplementary drug applications and becoming drug marketing license holders
Legal opinion of Beijing Dacheng Law Firm on the 2022 Annual General Meeting of Shareholders of Beijing Tongrentang Co., Ltd.
Tong Ren Tang\'s announcement on the election of the Chairman of the Supervisory Board
Announcement of Resolutions of Tong Ren Tang\'s 2022 Annual General Meeting of Shareholders
Analysis
Price Target
No Data
